Gambia vs Liberia: Death rate from Alzheimer's
Gambia
3.49 deaths per 100,000 people
in 2021
Liberia
3.44 deaths per 100,000 people
in 2021
Gambia rank
168th
Liberia rank
169th
Death rate from Alzheimer's over time
- Gambia
- Liberia
How they compare
Gambia currently reports 3.49 deaths per 100,000 people against 3.44 deaths per 100,000 people in Liberia, a difference of 0.05 deaths per 100,000 people.
Across all 22 years both countries report, Gambia has been ahead every year.
Gambia ranks 168th and Liberia ranks 169th of 194 countries.
Gambia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Gambia | Liberia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.34 deaths per 100,000 people | 2.89 deaths per 100,000 people | 2.45 deaths per 100,000 people | Gambia |
| 2010s | 3.9 deaths per 100,000 people | 3.29 deaths per 100,000 people | 0.608 deaths per 100,000 people | Gambia |
| 2020s | 3.62 deaths per 100,000 people | 3.47 deaths per 100,000 people | 0.14 deaths per 100,000 people | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from alzheimer's, Gambia or Liberia?
- Gambia, at 3.49 deaths per 100,000 people against 3.44 deaths per 100,000 people in Liberia as of 2021.
- What is the difference in death rate from alzheimer's between Gambia and Liberia?
- 0.05 deaths per 100,000 people, with Gambia ahead.
- How many years of comparable data are there for Gambia and Liberia?
- 22 years are reported by both, from 2000 to 2021.
- How do Gambia and Liberia rank globally for death rate from alzheimer's?
- Gambia ranks 168th and Liberia ranks 169th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from Alzheimer's. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from alzheimer disease and other dementias in both sexes, per 100,000 people.